DK vs REGN · rev $2.37B vs P/E 14, rev $14.34B
Delek US Energy Inc (DK) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Delek US Energy Inc (DK) is a oil & gas refining & marketing company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported DK revenue for 2024-12-31 was $2.37B. Net income was -$402.1M. Revenue was down 22.0% from 2024-09-30 to 2024-12-31. DK currently screens at market cap $2.96B.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
DK currently screens at market cap $2.96B. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the DK and REGN stock pages for the full models.
Not investment advice.